Back to search

Article

Integrating Human Genetics and Protective Genome Editing to Enable ADGRE2-Directed AML Therapy

2025-08-22

Abstract excerpt

<h4>ABSTRACT</h4> Acute myeloid leukemia (AML) remains a major therapeutic challenge due to extensive disease heterogeneity and lack of cancer-specific antigens. ADGRE2 has emerged as a promising AML target with broad expression in AML patient blast and leukemic stem cell-enriched populations. However, comparable expression in healthy hematopoietic stem and progenitor cells (HSPCs) and myeloid lineages suggests a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8a8dbc4b-decf-512b-b8bd-99e1315777ac
DOI
10.1101/2025.08.21.671614
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Integrating Human Genetics and Protective Genome Editing to Enable ADGRE2-Directed AML TherapyDOI 10.1101/2025.08.21.671614
Select a neighboring publication to make it the new centre.